Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Genetic preventive care with AI innovation

Reference number
Coordinator Arkus AI AB
Funding from Vinnova SEK 25 000
Project duration September 2023 - September 2023
Status Completed
Venture 2023-00007-en

Important results from the project

The goal was to travel to Israel to explore collaboration potentials in the area of genetic preventive care for all through AI innovation. We have achieved goals thanks to the fantastic support from colleagues at Business Sweden.

Expected long term effects

We have had very good results from the trip. We have established contact with the following orgnisations and researchers: 1, Sheba Medical Center 2, Clalit Health Services 3, Shaare Zedek Medical Center, 4, Jerusalem Hadassah Medical Center, and its Biohouse. 5, Investor: Pitango. There are a few addition contacts such as Leumit Health Services and Samson Assuta Ashdod University Hospital who can be our potential customers. We´ll also follow up with Prof Noam Shomron, at Tel Aviv university and a three other researchers to explore partnership to co-create.

Approach and implementation

The trip exceeded our expectation. We have established many more contacts than we planned. We´ll follow up and hope to implement at least one project in one of the areas: - customer reference case for Arkus AI digital tool for genetic counselling assistant and for genetic risk assessment - research partnership with one of the researchers - successful funding from one of the investors.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 10 November 2023

Reference number 2023-02465